bezafibrate has been researched along with Diabetic Nephropathies in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Izuhara, Y; Miyata, T | 1 |
| Arnold, R; Barth, M; Blech, M; Kaiser, H; Koop, I; Rumpf, KW; Scheler, F | 1 |
| Bruce, R; Cundy, T; Daniels, A | 1 |
| Benker, G; Cissewski, K; Kienast, K; Reinwein, D; Windeck, R | 1 |
1 trial(s) available for bezafibrate and Diabetic Nephropathies
| Article | Year |
|---|---|
Renal function changes in diabetic nephropathy induced by bezafibrate.
Topics: Bezafibrate; Diabetic Nephropathies; Humans; Hypolipidemic Agents; Kidney; Kidney Function Tests; Middle Aged | 1996 |
3 other study(ies) available for bezafibrate and Diabetic Nephropathies
| Article | Year |
|---|---|
Inhibition of advanced glycation end products: an implicit goal in clinical medicine for the treatment of diabetic nephropathy?
Topics: Angiotensin Receptor Antagonists; Antihypertensive Agents; Bezafibrate; Calcium Channel Blockers; Diabetic Nephropathies; Diet, Reducing; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Reactive Oxygen Species | 2008 |
[Bezafibrate-induced myolysis and myoglobinuria in patients with impaired renal function].
Topics: Aged; Bezafibrate; Creatine Kinase; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myoglobin; Myoglobinuria; Rhabdomyolysis | 1984 |
[Bezafibrate-induced myoglobinuric kidney failure in a 54-year-old patient with diabetes mellitus type IIa].
Topics: Acute Kidney Injury; Bezafibrate; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Female; Humans; Middle Aged; Myoglobinuria; Rhabdomyolysis | 1988 |